Clinical Pharmacist Participated in the treatment of three Lung Cancer Patients Taking Fentanyl
YIN Yue1, QIU Xin-ye2, ZHANG Yan-hua1*
1 Key Laboratory of Carcinogenesis and Translational Research ( Ministry of Education /Beijing), Department of Pharmacy，Peking University Cancer Hospital ＆ Institute, Beijing 100142; 2 Department of Pharmacy,Beijing YouAn hospital, Capital Medical Universty, Beijing,100069
Abstract：Objective: To ensure the safety and efficiency in cancer patients taking drugs by pharmaceutical care of clinical pharmacist. Methods: Through mastering the pharmacological effects, adverse reactions and precautions of Fentanyl clinical pharmacist undertook pharmaceutical care for three cancer patients using transdermal fentanyl patch. Results: Clinical pharmacist provided reasonable opinions and suggestions in the interaction of Fentanyl patch and Crizotinib and using 2.1mg Fentanyl patch in lung cancer patient with hepatic insufficiency. Finally, the patient successfully completed this period of treatment. Conclusion: With the pharmaceutical care of clinical pharmacist, the medication safety and efficiency in cancer patients has been ensured, and the standardized treatment of cancer pain has been promoted.
2017, Vol. 15 
